Benign Synthesis of Thiazolo-androstenone Derivatives as Potent Anticancer Agents
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
P20 GM103429
NIGMS NIH HHS - United States
P20 RR016460
NCRR NIH HHS - United States
PubMed
30204455
PubMed Central
PMC6441354
DOI
10.1021/acs.orglett.8b02587
Knihovny.cz E-resources
- MeSH
- Androstenes chemistry pharmacology MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Neoplasms drug therapy pathology MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- Density Functional Theory MeSH
- Thiazoles chemistry pharmacology MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Names of Substances
- androst-16-en-3-one MeSH Browser
- Androstenes MeSH
- Antineoplastic Agents MeSH
- Thiazoles MeSH
An unprecedented reaction of thiourea derivatives with 6β-bromoandrostenedione has been discovered for the formation of aminothiazolo-androstenones via a simple, safer, cascade protocol that enables the syntheses of novel molecules by using readily available reagents. The reaction mechanism of product formation has been rationalized by density functional theory calculations. This benign methodology accentuates a domino protocol deploying a renewable solvent, ethanol, while generating novel compounds that display potent growth inhibitory effects in in vitro studies for several cancer cell lines at submicromolar concentrations.
See more in PubMed
Cheskis BJ Regulation of cell signalling cascades by steroid hormones. J. Cell. Biochem 2004, 93, 20–27. PubMed
Wilkenfeld SR; Lin C; Frigo DE Communication between genomic and non-genomic signaling events coordinate steroid hormone actions. Steroids 2018, 133, 2–7. PubMed PMC
Dai J; Yoshida WY; Kelly M; Williams P Pregnane-10,2-carbolactones from a Hawaiian Marine Sponge in the Genus Myrmekioderma. J. Nat. Prod 2016, 79, 1464–7. PubMed PMC
Liu J; Zhang D; Sun X; Ding T; Lei B; Zhang C Structure-activity relationship of brassinosteroids and their agricultural practical usages. Steroids 2017, 124, 1–17. PubMed
Calle JM; Pérez AJ; Simonet AM; Guerra JO; Macías FA Steroidal Saponins from Furcraea hexapetala Leaves and Their Phytotoxic Activity. J. Nat. Prod 2016, 79, 2903–2911. PubMed
Kudova E; Chodounska H; Slavikova B; Budesinsky M; Nekardova M; Vyklicky V; Krausova B; Svehla P; Vyklicky L A New Class of Potent N-Methyl-D-Aspartate Receptor Inhibitors: Sulfated Neuroactive Steroids with Lipophilic D-Ring Modifications. J. Med. Chem 2015, 58, 5950–66. PubMed
Festa C; Renga B; D’Amore C; Sepe V; Finamore C; De Marino S; Carino A; Cipriani S; Monti MC; Zampella A; Fiorucci S Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands. J. Med. Chem 2014, 57, 8477–95. PubMed
Sepe V; Renga B; Festa C; D’Amore C; Masullo D; Cipriani S; Di Leva FS; Monti MC; Novellino E; Limongelli V; Zampella A; Fiorucci S Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). J. Med. Chem 2014, 57, 7687–701. PubMed
Qian M; Krishnan K; Kudova E; Li P; Manion BD; Taylor A; Elias G; Akk G; Evers AS; Zorumski CF; Mennerick S; Covey DF Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of gamma-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone. J. Med. Chem 2014, 57, 171–90. PubMed PMC
Bansal R; Acharya PC Man-made cytotoxic steroids: exemplary agents for cancer therapy. Chem. Rev 2014, 114, 6986–7005. PubMed
Le Bideau F; Dagorne S Synthesis of transition-metal steroid derivatives. Chem. Rev 2013, 113, 7793–850. PubMed
El-Desoky E-SI; Reyad M; Afsah EM; Dawidar AA Synthesis and chemical reactions of the steroidal hormone 17alpha-methyltestosterone. Steroids 2016, 105, 68–95. PubMed
Moreno Y Banuls L; Urban E; Gelbcke M; Dufrasne F; Kopp B; Kiss R; Zehl M Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells. J. Nat. Prod 2013, 76, 1078–84. PubMed
Ning X; Yang Y; Deng H; Zhang Q; Huang Y; Su Z; Fu Y; Xiang Q; Zhang S Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy. Steroids 2017, 121, 10–16. PubMed
Ji ZH; Xu ZQ; Zhao H; Yu XY Neuroprotective effect and mechanism of daucosterol palmitate in ameliorating learning and memory impairment in a rat model of Alzheimer’s disease. Steroids 2017, 119, 31–35. PubMed
Larik FA; Saeed A; Shahzad D; Faisal M; El-Seedi H; Mehfooz H; Channar PA Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives. Steroids 2017, 118, 76–92. PubMed
Rouf A; Tanyeli C Bioactive thiazole and benzothiazole derivatives. Eur. J. Med. Chem 2015, 97, 911–927. PubMed
Ayati A; Emami S; Asadipour A; Shafiee A; Foroumadi A Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur. J. Med. Chem 2015, 97, 699–718. PubMed
FDA. FDA approves drug to treat Duchenne muscular dystrophy. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm540945.htm.
Madhra MK; Sriram HM; Inamdar M; Sharma MK; Prasad M; Joseph S Improved Procedure for Preparation of Abiraterone Acetate. Org. Process Res. Dev 2014, 18, 555–558.
Szychowski J; Truchon J-F; Bennani YL Natural Products in Medicine: Transformational Outcome of Synthetic Chemistry. J. Med. Chem 2014, 57, 9292–9308. PubMed
Antonarakis ES; Bastos DA Galeterone for the treatment of advanced prostate cancer: the evidence to date. Drug Des., Dev. Ther 2016, 10, 2289–97. PubMed PMC
Fuke C; Arao T In Oleander toxins; Springer GmbH, 2005; pp 519–526.
Vitellozzi L; McAllister GD; Genski T; Taylor RJK Organometallic Routes to Novel Steroids Containing Heterocyclic C-17 Side-Chains. Synthesis 2016, 48, 48–56.
Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM Synthesis and biological evaluation of dehydroepiandroster-one-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues. Steroids 2014, 80, 92–101. PubMed
Martinez Botella G; Salituro FG; Harrison BL; Beresis RT; Bai Z; Shen K; Belfort GM; Loya CM; Ackley MA; Grossman SJ; Hoffmann E; Jia S; Wang J; Doherty JJ; Robichaud AJ Neuroactive Steroids. 1. Positive Allosteric Modulators of the (gamma-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21. J. Med. Chem 2015, 58, 3500–11. PubMed
Li J; Huo H; Guo R; Liu B; Li L; Dan W; Xiao X; Zhang J; Shi B Facile and efficient access to Androsten-17-(1’,3′,4’)-pyrazoles and Androst-17beta-(1’,3′,4’)-pyrazoles via Vilsmeier reagents, and their antiproliferative activity evaluation in vitro. Eur. J. Med. Chem 2017, 130, 1–14. PubMed
Metz TL; Lutovsky GA; Stanley LM An Acid-Catalyzed Addition and Dehydration Sequence for the Synthesis of Heteroarylated Steroidal Dienes. J. Org. Chem 2018, 83, 1643–1648. PubMed
Ambrose AJ; Santos EA; Jimenez PC; Rocha DD; Wilke DV; Beuzer P; Axelrod J; Kanduluru AK; Fuchs PL; Cang H; Costa-Lotufo LV; Chapman E; Clair JJL Ritterostatin GN1N, a Cephalostatin–Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78. ChemBioChem 2017, 18, 506–510. PubMed PMC
Zolottsev VA; Tkachev YV; Latysheva AS; Kostin VA; Novikov RA; Timofeev VP; Morozevich GE; Kuzikov AV; Shumyantseva VV; Misharin AY Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth. Steroids 2018, 129, 24–34. PubMed
Michalak K; Morawiak M; Wicha J Synthetic Approach to the Core Structure of Oleandrin and Related Cardiac Glycosides with Highly Functionalized Ring D. Org. Lett 2016, 18, 6148–6151. PubMed
Metz TL; Lutovsky GA; Stanley LM An Acid-Catalyzed Addition and Dehydration Sequence for the Synthesis of Heteroarylated Steroidal Dienes. J. Org. Chem 2018, 83, 1643. PubMed
Alam MA; Alsharif Z; Alkhattabi H; Jones D; Delancey E; Gottsponer A; Yang T Hexafluoroisopropyl alcohol mediated synthesis of 2,3-dihydro-4H-pyrido[1,2-a]pyrimidin-4-ones. Sci. Rep 2016, 6, 36316. PubMed PMC
Alam MA, Cytotoxic agents, anticancer agents and the method of synthesizing the cytotoxic and anticancer agents. Provisional Patent filed, 2018.
Allison D; Delancey E; Ramey H; Williams C; Alsharif ZA; Al-khattabi H; Ontko A; Gilmore D; Alam MA Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents. Bioorg. Med. Chem. Lett 2017, 27, 387–392. PubMed PMC
Alsharif Z; Ali MA; Alkhattabi H; Jones D; Delancey E; Ravikumar PC; Alam MA Hexafluoroisopropanol mediated benign synthesis of 2H-pyrido[1,2-a]pyrimidin-2-ones by using a domino protocol. New J. Chem 2017, 41, 14862–14870. PubMed PMC
Alsharif ZA; Alam MA Modular synthesis of thiazoline and thiazole derivatives by using a cascade protocol. RSC Adv. 2017, 7, 32647–32651. PubMed PMC
NCI. The NCI Development Therapeutics Program (DTP) https://dtp.cancer.gov/ (accessed Feb 17, 2016).
Holbeck SL; Collins JM; Doroshow JH Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines. Mol. Cancer Ther 2010, 9, 1451–60. PubMed PMC